Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Rokt Ltd. investment portfolio
Rokt Ltd. has made numerous investments in companies such as Nevrargenics, Trunk Works, and Molecular Twins within the Healthcare & Life Sciences sector.
unknown
Portfolio
3
Team
0
Portfolio (3)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Molecular Twins Ltd Molecular Twins Ltd provides pharmaceutical, biotech, and consumer‑health companies with study‑design services, high‑quality data collection, integrated analytics, and a minimally invasive microbiopsy technology that captures transcriptomic skin data for research in dermatology, immunology and regenerative medicine. | Healthcare & Life Sciences | London | Confirmed | 2026-02-18 |
| Nevrargenics Limited NEVRARGENICS LIMITED is a UK-based drug discovery and development company that focuses on creating innovative medicines for neurodegenerative diseases like Alzheimer's, Parkinson's, and Amyotrophic Lateral Sclerosis. They develop dual-acting retinoic acid receptor modulators (RAR-Ms) designed to trigger neuroprotection and nerve regeneration. | Healthcare & Life Sciences | Stockton-On-Tees | Confirmed | 2026-01-23 |
Backs Similar Companies
Investors who tend to invest in the same sort of companies.
5 more similar investors hiddenSign up to unlock →
Shareholding changes (1)
Sign up free to see when this investor has bought or sold shares.
Sign up free